학술논문
Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial
Document Type
Article
Author
Source
In The Lancet Diabetes & Endocrinology May 2022 10(5):330-340
Subject
Language
ISSN
2213-8587